Estimate Recalculated Oct 6, 2025 08:24PM EST
Casdin Capital, LLC has an estimated net worth of $93.6 Million. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Absci Corp, BIOLIFE SOLUTIONS INC, MAXCYTE, INC., GeneDx Holdings Corp., 2seventy bio, Inc., Generation Bio Co., and Tenaya Therapeutics, Inc..
Casdin Capital, LLC's CIK is 0001534261
2024 was Casdin Capital, LLC's most active year for acquiring shares with 11 total transactions. Casdin Capital, LLC's most active month to acquire stocks was the month of April. 2024 saw Casdin Capital, LLC paying a total of $8,595,013.82 for 448,975 shares, this is the most they've acquired in one year.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!